Breaking News Instant updates and real-time market news.

EVH

Evolent Health

$6.75

-0.79 (-10.48%)

10:00
12/17/19
12/17
10:00
12/17/19
10:00

Evolent Health falls -10.5%

Evolent Health is down -10.5%, or -79c to $6.73.

EVH Evolent Health
$6.75

-0.79 (-10.48%)

12/04/19
RHCO
12/04/19
NO CHANGE
Target $14
RHCO
Buy
Evolent Health price target lowered to $14 from $17 at SunTrust
SunTrust analyst Sandy Draper lowered his price target on Evolent Health to $14, updating his model after last week's announced loss of a Medicaid contract in Kentucky. The analyst notes that after his call with the company's management, his model now assumes a Service revenue growth of about 11% in FY20 and flat in FY21, down from 20% and 15% prior projections respectively. The analyst still keeps his Buy rating on Evolent Health, which he sees as a "unique play on the transformative shift from the current fee for service environment to value based care in the U.S."
12/10/19
WBLR
12/10/19
NO CHANGE
WBLR
Outperform
William Blair says Passport may get appeal or new RFP under new Kentucky leaders
William Blair analyst Ryan Daniels noted that yesterday the State of Kentucky's Contract Review Committee voted unanimously by a 6-0 vote not to approve outgoing Governor Matt Bevin's administration's decision to award the state's Managed Medicaid contracts to five national insurers. The committee's co-chairs will now send a letter to Holly McCoy-Johnson, who was named the new finance secretary under governor-elect Andy Beshear, noted Daniels. He believes the new administration could either grant an appeal to either Passport or Anthem, who are the two incumbents not awarded contracts, or reissue a new request for proposal and give the incumbents a second chance. Daniels also highlighted that ex-Passport CEO Mark Carter is on Governor-elect Beshear's transition team and Daniels believes he will be involved in choosing appointees who could be influential in the above-mentioned options. The analyst, who sees an attractive risk/reward for Evolent given the latest news and the stock's underperformance since news regarding the lost Kentucky Managed Medicaid bid, has an Outperform rating on Evolent Health shares.
12/12/19
CANT
12/12/19
NO CHANGE
Target $10
CANT
Overweight
Evolent partner could still win Kentucky contract, says Cantor Fitzgerald
Evolent Health shares dropped sharply yesterday, then recovered, after Kentucky media reports indicated that the outgoing administration overrode the legislative committee's rejection of the Medicaid awards, Cantor Fitzgerald analyst Steven Halper tells investors in a research note. For now, all of the recently awarded contracts remain in place, he adds. Halper assumes the incoming Beshear administration will review the contract decisions, however. He keeps an Overweight rating on Evolent Health shares with a $10 price target, which assumes no contribution from Passport. Nonetheless, the analyst believes it is possible that Passport will be awarded a contract following the Bevin administration's review. Still, visibility into the ultimate outcome of the process is low, Halper cautions.
12/12/19
CANT
12/12/19
NO CHANGE
Target $10
CANT
Overweight
Evolent partner could still win Kentucky contract, says Cantor Fitzgerald
Evolent Health shares dropped sharply yesterday, then recovered, after Kentucky media reports indicated that the outgoing administration overrode the legislative committee's rejection of the Medicaid awards, Cantor Fitzgerald analyst Steven Halper tells investors in a research note. For now, all of the recently awarded contracts remain in place, he adds. Halper assumes the incoming Beshear administration will review the contract decisions, however. He keeps an Overweight rating on Evolent Health shares with a $10 price target, which assumes no contribution from Passport. Nonetheless, the analyst believes it is possible that Passport will be awarded a contract following the Bevin administration's review. Still, visibility into the ultimate outcome of the process is low, Halper cautions.

TODAY'S FREE FLY STORIES

BA

Boeing

$325.18

-6.82 (-2.05%)

13:46
01/17/20
01/17
13:46
01/17/20
13:46
Periodicals
Boeing tells CNBC 'making necessary updates' to MAX after report of new issue »

After ABC's David…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

BA

Boeing

$326.24

-5.76 (-1.73%)

13:43
01/17/20
01/17
13:43
01/17/20
13:43
Hot Stocks
Breaking Hot Stocks news story on Boeing »

Boeing down 2% to $325.88…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

VB

Vanguard Small-Cap Index Fund

$169.72

-0.13 (-0.08%)

, IVV

iShares Core S&P 500

$333.10

0.72 (0.22%)

13:43
01/17/20
01/17
13:43
01/17/20
13:43
Technical Analysis
On The Fly: ETF fund flow highlights »

For the week creations…

VB

Vanguard Small-Cap Index Fund

$169.72

-0.13 (-0.08%)

IVV

iShares Core S&P 500

$333.10

0.72 (0.22%)

TLT

iShares 20+ Year Treasury Bond Fund

$138.05

-1.15 (-0.83%)

ESGU

iShares ESG MSCI U.S.A. ETF

$73.74

0.27 (0.37%)

VCSH

Vanguard Short-Term Corporate Bond Index Fund

$81.21

0.025 (0.03%)

SPY

SPDR S&P 500 ETF Trust

$331.63

0.73 (0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$326.27

-5.73 (-1.73%)

13:42
01/17/20
01/17
13:42
01/17/20
13:42
Periodicals
ABC learns of another software issue with Boeing 737 Max »

ABC's David Kerley…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

JNJ

Johnson & Johnson

$148.97

0.72 (0.49%)

13:39
01/17/20
01/17
13:39
01/17/20
13:39
Periodicals
Judge slashes J&J verdict down to $6.8M from $8B in Risperdal suit, Law.com says »

Philadelphia Court of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 09

    Mar

  • 17

    Mar

JNJ

Johnson & Johnson

$149.03

0.78 (0.53%)

13:17
01/17/20
01/17
13:17
01/17/20
13:17
Periodicals
Judge cuts J&J punishment in Risperdal case to $6.8M from $8B, Bloomberg reports »

On October 8, 2019,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 09

    Mar

  • 17

    Mar

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
01/17/20
01/17
13:17
01/17/20
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
01/17/20
01/17
13:16
01/17/20
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BKR

Baker Hughes

$23.56

0.06 (0.26%)

13:04
01/17/20
01/17
13:04
01/17/20
13:04
Hot Stocks
Baker Hughes reports U.S. rig count up 15 to 796 rigs »

Baker Hughes reports that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 23

    Mar

MDR

McDermott

$0.73

0.0119 (1.66%)

13:02
01/17/20
01/17
13:02
01/17/20
13:02
Hot Stocks
McDermott announces start of commercial operation of Freeport LNG Train 2 »

McDermott International,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$240.69

0.17 (0.07%)

13:02
01/17/20
01/17
13:02
01/17/20
13:02
Recommendations
Amgen analyst commentary  »

Amgen raised prices today…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

BKR

Baker Hughes

$23.57

0.07 (0.30%)

13:01
01/17/20
01/17
13:01
01/17/20
13:01
Hot Stocks
Breaking Hot Stocks news story on Baker Hughes »

Baker Hughes reports U.S.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 23

    Mar

SNCA

Seneca Biopharma

$3.09

1.84 (147.20%)

12:59
01/17/20
01/17
12:59
01/17/20
12:59
Hot Stocks
Seneca Biopharma surges after saying talks starting with 'interested parties' »

Shares of micro-cap…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AUPH

Aurinia Pharmaceuticals

$20.02

0.19 (0.96%)

12:45
01/17/20
01/17
12:45
01/17/20
12:45
Options
Aurinia Pharmaceuticals call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:45
01/17/20
01/17
12:45
01/17/20
12:45
General news
Breaking General news story  »

Week of 1/17 Baker-Hughes…

12:45
01/17/20
01/17
12:45
01/17/20
12:45
General news
Breaking General news story  »

Week of 1/17 Baker-Hughes…

DLAKY

Lufthansa

$0.00

(0.00%)

12:41
01/17/20
01/17
12:41
01/17/20
12:41
Periodicals
Lufthansa extends Tehran flight halt until March 28, Reuters reports »

Lufthansa said that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TM

Toyota

$139.71

-0.32 (-0.23%)

12:36
01/17/20
01/17
12:36
01/17/20
12:36
Hot Stocks
Toyota provides outline of production alignment through 2022 »

To "improve the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TM

Toyota

$139.71

-0.32 (-0.23%)

12:33
01/17/20
01/17
12:33
01/17/20
12:33
Hot Stocks
Toyota Indiana completes $1.3B modernization, adds 550 new jobs »

Toyota Indiana invested…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:30
01/17/20
01/17
12:30
01/17/20
12:30
General news
Treasury Dealer Agenda: the dealer meeting will be held on January 30, 31 »

Treasury Dealer Agenda:…

12:30
01/17/20
01/17
12:30
01/17/20
12:30
General news
Breaking General news story  »

Federal Reserve Board of…

12:30
01/17/20
01/17
12:30
01/17/20
12:30
General news
Breaking General news story  »

Federal Reserve Board of…

AXTA

Axalta Coating

$30.30

0.225 (0.75%)

12:25
01/17/20
01/17
12:25
01/17/20
12:25
Options
Axalta Coating call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

12:25
01/17/20
01/17
12:25
01/17/20
12:25
Conference/Events
Federal Reserve Board of Governors Vice Chairman speaks at a meeting »

Randal Quarles, Vice…

MSFT

Microsoft

$165.58

-0.66 (-0.40%)

, WORK

Slack Technologies

$22.68

-0.28 (-1.22%)

12:23
01/17/20
01/17
12:23
01/17/20
12:23
Periodicals
Microsoft to launch global ad campaign for Teams, CNBC reports »

Microsoft (MSFT) will…

MSFT

Microsoft

$165.58

-0.66 (-0.40%)

WORK

Slack Technologies

$22.68

-0.28 (-1.22%)

IPG

Interpublic Group

$23.96

0.22 (0.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

  • 12

    Feb

  • 25

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.